{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T19:47:45Z","timestamp":1777751265285,"version":"3.51.4"},"reference-count":63,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2018,11,9]],"date-time":"2018-11-09T00:00:00Z","timestamp":1541721600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1007\/s00277-018-3536-x","type":"journal-article","created":{"date-parts":[[2018,11,9]],"date-time":"2018-11-09T06:57:55Z","timestamp":1541746675000},"page":"289-299","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Genetic determinants related to pharmacological induction of foetal haemoglobin in transfusion-dependent HbE-\u03b2 thalassaemia"],"prefix":"10.1007","volume":"98","author":[{"given":"Sujana","family":"Biswas","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arijit","family":"Nag","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kanjaksha","family":"Ghosh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rudra","family":"Ray","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kaushik","family":"Roy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anish","family":"Bandyopadhyay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6984-168X","authenticated-orcid":false,"given":"Maitreyee","family":"Bhattacharyya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,11,9]]},"reference":[{"key":"3536_CR1","doi-asserted-by":"publisher","first-page":"480","DOI":"10.2471\/BLT.06.036673","volume":"86","author":"B Modell","year":"2008","unstructured":"Modell B, Darlison M (2008) Global epidemiology of haemoglobin disorders and derived service indicators. Bull World Health Organ 86:480\u2013487","journal-title":"Bull World Health Organ"},{"key":"3536_CR2","first-page":"704","volume":"79","author":"DJ Weatherall","year":"2001","unstructured":"Weatherall DJ, Clegg JB (2001) Inherited haemoglobin disorders: an increasing global health problem. Bull World Health Organ 79:704\u2013712","journal-title":"Bull World Health Organ"},{"issue":"2","key":"3536_CR3","doi-asserted-by":"publisher","first-page":"116","DOI":"10.4103\/0974-2727.180793","volume":"8","author":"SS Kiran","year":"2016","unstructured":"Kiran SS, Aithal S, Belagavi CS (2016) Hemoglobin E hemoglobinopathy in an adult from Assam with unusual presentation: a diagnostic dilemma. J Lab Physicians 8(2):116\u2013119","journal-title":"J Lab Physicians"},{"key":"3536_CR4","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1007\/s12687-012-0114-0","volume":"4","author":"D Mohanty","year":"2013","unstructured":"Mohanty D, Colah RB, Gorakshakar AC, Patel RZ, Master DC, Mahanta J, Sharma SK, Chaudhari U, Ghosh M, Das S, Britt RP, Singh S, Ross C, Jagannathan L, Kaul R, Shukla DK, Muthuswamy V (2013) Prevalence of \u03b2-thalassemia and other haemoglobinopathies in six cities in India: a multicentre study. J Community Genet 4:33\u201342","journal-title":"J Community Genet"},{"key":"3536_CR5","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1159\/000153796","volume":"38","author":"R Deka","year":"1988","unstructured":"Deka R, Reddy AP, Mukherjee BN, Das BM, Banerjee S, Roy M, Dey B, Malhotra KC, Walter H (1988) Hemoglobin E distribution in ten endogamous population groups of Assam, India. Hum Hered 38:261\u2013266","journal-title":"Hum Hered"},{"key":"3536_CR6","first-page":"a011734","volume":"2","author":"S Fuchareon","year":"2012","unstructured":"Fuchareon S, Weatherall DJ (2012) The hemoglobin E thalassemias. Cold Spring Harb Perspect Med 2:a011734","journal-title":"Cold Spring Harb Perspect Med"},{"key":"3536_CR7","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1038\/300768a0","volume":"300","author":"SH Orkin","year":"1982","unstructured":"Orkin SH, Kazazian HH, Antonarakis SE, Ostrer H, Goff SC, Sexton JP (1982) Abnormal RNA processing due to the exon mutation of \u03b2E-globin gene. Nature 300:768\u2013769","journal-title":"Nature"},{"key":"3536_CR8","doi-asserted-by":"crossref","unstructured":"Weatherall DJ, Clegg JB: The thalassaemia syndromes. 3rd. Blackwell Scientific; 2001","DOI":"10.1002\/9780470696705"},{"key":"3536_CR9","doi-asserted-by":"publisher","first-page":"a011627","DOI":"10.1101\/cshperspect.a011627","volume":"2","author":"RC Hardison","year":"2012","unstructured":"Hardison RC (2012) Evolution of hemoglobin and its genes. Cold Spring Harb Perspect Med 2:a011627","journal-title":"Cold Spring Harb Perspect Med"},{"key":"3536_CR10","doi-asserted-by":"publisher","first-page":"2081","DOI":"10.1182\/blood-2006-04-015859","volume":"108","author":"PA Oneal","year":"2006","unstructured":"Oneal PA, Gantt NM, Schwartz JD, Bhanu NV, Lee YT, Moroney JW, Reed CH, Schechter AN, Luban NLC, Miller JL (2006) Fetal hemoglobin silencing in humans. Blood 108:2081\u20132086","journal-title":"Blood"},{"key":"3536_CR11","volume-title":"Molecular basis of blood diseases, ed 3","author":"G Stamatoyannopoulos","year":"2001","unstructured":"Stamatoyannopoulos G, Nienhuis AW (2001) Molecular basis of blood diseases, ed 3. Saunders, Philadelphia, PA"},{"issue":"1","key":"3536_CR12","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/S0950-3536(05)80070-8","volume":"6","author":"WG Wood","year":"1993","unstructured":"Wood WG (1993) Increased HbF in adult life. Baillieres Clin Haematol 6(1):177\u2013213","journal-title":"Baillieres Clin Haematol"},{"issue":"3","key":"3536_CR13","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1002\/1096-8652(200011)65:3<227::AID-AJH9>3.0.CO;2-V","volume":"65","author":"BS Baliga","year":"2000","unstructured":"Baliga BS, Pace BS, Chen HH, Shah AK, Yang YM (2000) Mechanism for fetal hemoglobin induction by hydroxyurea in sickle cell erythroid progenitors. Am J Hematol 65(3):227\u2013233","journal-title":"Am J Hematol"},{"key":"3536_CR14","doi-asserted-by":"publisher","first-page":"S177","DOI":"10.3109\/03630260903351809","volume":"33","author":"M Karimi","year":"2009","unstructured":"Karimi M (2009) Hydroxyurea in the management of thalassemia intermedia. Hemoglobin 33:S177\u2013S182","journal-title":"Hemoglobin"},{"issue":"1","key":"3536_CR15","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1182\/blood-2011-03-325258","volume":"118","author":"I Akinsheye","year":"2011","unstructured":"Akinsheye I, Alsultan A, Solovieff N, Ngo D, Baldwin CT, Sebastiani P, Chui DHK, Steinberg MH (2011) Fetal hemoglobin in sickle cell anemia. Blood 118(1):19\u201327","journal-title":"Blood"},{"key":"3536_CR16","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1586\/17474086.2015.1078235","volume":"8","author":"GD Pule","year":"2015","unstructured":"Pule GD, Mowla S, Novitzky N, Wiysonge CS, Wonkam A (2015) A systematic review of known mechanisms of hydroxyurea-induced foetal haemoglobin for treatment of sickle cell disease. Expert Rev Haematol 8:669\u2013679","journal-title":"Expert Rev Haematol"},{"key":"3536_CR17","first-page":"135","volume-title":"The molecular basis of blood diseases","author":"G Stamatoyannopoulos","year":"2001","unstructured":"Stamatoyannopoulos G, Grosveld F (2001) The molecular basis of blood diseases, 3rd edn. W. B. Saunders, Philadelphia, pp 135\u2013182","edition":"3"},{"issue":"1","key":"3536_CR18","doi-asserted-by":"publisher","first-page":"a011643","DOI":"10.1101\/cshperspect.a011643","volume":"3","author":"VG Sankaran","year":"2013","unstructured":"Sankaran VG, Orkin SH (2013) The switch from foetal to adult haemoglobin. Cold Spring Harb Perspect Med 3(1):a011643","journal-title":"Cold Spring Harb Perspect Med"},{"key":"3536_CR19","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/S0950-3536(98)80072-3","volume":"11","author":"DJ Weatherall","year":"1998","unstructured":"Weatherall DJ (1998) Pathophysiology of thalassaemia. Baillieres Clin Haematol 11:127\u2013146","journal-title":"Baillieres Clin Haematol"},{"key":"3536_CR20","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1038\/35066048","volume":"2","author":"DJ Weatherall","year":"2001","unstructured":"Weatherall DJ (2001) Phenotype-genotype relationships in monogenic disease: lessons from the thalassaemias. Nat. Rev. Genet. 2:245\u2013255","journal-title":"Nat. Rev. Genet."},{"issue":"27","key":"3536_CR21","doi-asserted-by":"publisher","first-page":"11346","DOI":"10.1073\/pnas.0611393104","volume":"104","author":"SL Thein","year":"2007","unstructured":"Thein SL, Menzel S, Peng X, Best S, Jiang J, Close J, Silver N, Gerovasilli A, Ping C, Yamaguchi M, Wahlberg K, Ulug P, Spector TD, Garner C, Matsuda F, Farrall M, Lathrop M (2007) Itergenic variations of HBS1L-MYB are responsible for a major quantitative trait locus on chromosome 6q23 influencing fetal haemoglobin levels in adult. ProcNatlAcadSci USA 104(27):11346\u201311351","journal-title":"ProcNatlAcadSci USA"},{"issue":"10","key":"3536_CR22","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1038\/ng2108","volume":"39","author":"S Menzel","year":"2007","unstructured":"Menzel S, Garner C, Gut I, Matsuda F, Yamaguchi M, Heath S, Foglio M, Zelenika D, Boland A, Rooks H, Best S, Spector TD, Farrall M, Lathrop M, Thein SL (2007) A QTL influencing F cell production maps to a gene encoding a zinc-finger protein on chromosome 2p15. Nat. Genet. 39(10):1197\u20131199","journal-title":"Nat. Genet."},{"issue":"6","key":"3536_CR23","doi-asserted-by":"publisher","first-page":"592","DOI":"10.3109\/03630269.2012.735626","volume":"36","author":"P Roy","year":"2012","unstructured":"Roy P, Bhattacharyya G, Mandal A, Dasgupta UB, Banerjee D, Chandra S, Das M (2012) Influence of BCL11A, HBS1L-MYB, HBBP1 single nucleotide polymorphisms and the HBG2 XmnI polymorphism on HbF levels. Hemoglobin 36(6):592\u2013599","journal-title":"Hemoglobin"},{"issue":"3","key":"3536_CR24","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1007\/s00439-009-0770-2","volume":"127","author":"M Nuinoon","year":"2010","unstructured":"Nuinoon M, Makarasara W, Mushiroda T, Setianingsih I, Wahidiyat PA, Sripichai O, Kumasaka N, Takahashi A, Svasti S, Munkongdee T, Mahasirimongkol S, Peerapittayamongkol C, Viprakasit V, Kamatani N, Winichagoon P, Kubo M, Nakamura Y, Fucharoen S (2010) A genome-wide association identified the common genetic variants influence disease severity in \u03b2\u00b0-thalassemia \/ hemoglobin E. Hum. Genet. 127(3):303\u2013314","journal-title":"Hum. Genet."},{"issue":"108","key":"3536_CR25","first-page":"1471","volume":"15","author":"P Fanis","year":"2014","unstructured":"Fanis P, Kousiappa I, Phylactides M, Kleanthous M (2014) Genotyping of BCL11A and HBS1L-MYB SNPs associated with fetal haemoglobin levels: a SNaPshotminisequencing approach. BMC Genomics 15(108):1471\u20132164","journal-title":"BMC Genomics"},{"issue":"11","key":"3536_CR26","doi-asserted-by":"publisher","first-page":"1712","DOI":"10.3324\/haematol.2011.046748","volume":"96","author":"C Badens","year":"2011","unstructured":"Badens C, Joly P, Agouti I, Thuret I, Gonnet K, Fattoum S, Francina A, Simeoni MC, Loundou A, Pissard S (2011) Variants in genetic modifiers of \u03b2-thalassemia can help to predict the major or intermedia type of the disease. Haematologica 96(11):1712\u20131714","journal-title":"Haematologica"},{"key":"3536_CR27","doi-asserted-by":"crossref","unstructured":"Rosnah B, Rosline H, Zaidah AW, Noor Haslina MN, Marini R, Shafini MY, Nurul Ain FA: Detection of common deletional Alpha-Thalassaemia spectrum by molecular technique in Kelantan, Northeastern Malaysia. Isrn Haematology. 2012; article ID 462969: 3 pgs","DOI":"10.5402\/2012\/462969"},{"issue":"12","key":"3536_CR28","doi-asserted-by":"publisher","first-page":"2199","DOI":"10.1182\/blood-2012-10-408021","volume":"121","author":"KM Musallam","year":"2013","unstructured":"Musallam KM, Taher AT, Cappellini MD, Sankaran VG (2013) CME article. Clinical experience with fetal hemoglobin induction therapy in patients with \u03b2 thalassemia. Blood 121(12):2199\u20132212","journal-title":"Blood"},{"issue":"3","key":"3536_CR29","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1111\/j.1365-2141.2008.07126.x","volume":"141","author":"NF Olivieri","year":"2008","unstructured":"Olivieri NF, Muraca GM, O'Donnell A, Premawardhena A, Fisher C, Weatherall DJ (2008) Studies in haemoglobin E beta-thalassaemia. Br. J. Haematol. 141(3):388\u2013397","journal-title":"Br. J. Haematol."},{"key":"3536_CR30","doi-asserted-by":"crossref","unstructured":"Dixit A, Chatterjee TC, Mishra P, Choudhry DR, Mahapatra M, Tyagi S, et al: Hydroxyurea in thalassemia intermedia\u2014a promising therapy. Ann Hematol. 2005 Jul 19 [cited 2016 Dec 25]; 84(7): 441\u20136]","DOI":"10.1007\/s00277-005-1026-4"},{"key":"3536_CR31","doi-asserted-by":"publisher","first-page":"1689","DOI":"10.1007\/s00277-018-3357-y","volume":"97","author":"SA Kalantri","year":"2018","unstructured":"Kalantri SA, Ray R, Chattopadhyay A, Bhattacharjee S, Biswas A, Bhattacharyya M (2018) Efficacy of decitabine as hemoglobin F inducer in HbE\/\u03b2-thalassemia. Ann. Hematol. 97:1689\u20131694. \n                    https:\/\/doi.org\/10.1007\/s00277-018-3357-y","journal-title":"Ann. Hematol."},{"issue":"6","key":"3536_CR32","doi-asserted-by":"publisher","first-page":"e18028","DOI":"10.5812\/ircmj.18028","volume":"16","author":"MR Bordbar","year":"2014","unstructured":"Bordbar MR, Silavizadeh S, Haghpanah S, Kamfiroozi R, Bardestani M, Karimi M (2014) Hydroxyurea treatment in transfusion-dependent \u03b2-thalassemia patients. Iran Red Crescent Med J 16(6):e18028","journal-title":"Iran Red Crescent Med J"},{"key":"3536_CR33","first-page":"98","volume-title":"Laboratory manual for screening diagnosis and molecular analysis of haemoglobinopathies and red cell enzymopathies","author":"R Colah","year":"2008","unstructured":"Colah R, Mohanty D (2008) Laboratory manual for screening diagnosis and molecular analysis of haemoglobinopathies and red cell enzymopathies. Bhilani Publishing House, Mumbai India, pp 98\u2013101"},{"issue":"33","key":"3536_CR34","doi-asserted-by":"publisher","first-page":"11869","DOI":"10.1073\/pnas.0804799105","volume":"105","author":"G Lettre","year":"2008","unstructured":"Lettre G, Sankaran VG, Bezerra MA et al (2008) DNA polymorphisms at the BCL11A, HBS1L-MYB and \u03b2-globin gene associate with fetal haemoglobin levels and pain crises in sickle cell disease. Proc. Natl. Acad. Sci. U. S. A. 105(33):11869\u201311874","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"3536_CR35","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.ejmhg.2014.12.005","volume":"16","author":"F Said","year":"2015","unstructured":"Said F, Abdel-Salam A (2015) XmnI polymorphism: relation to \u03b2-thalassaemia phenotype and genotype in Egyptian children. The Egyptian Jourmal of Medical Human Genetics 16:123\u2013127","journal-title":"The Egyptian Jourmal of Medical Human Genetics"},{"issue":"10","key":"3536_CR36","doi-asserted-by":"publisher","first-page":"1679","DOI":"10.1373\/49.10.1679","volume":"49","author":"W Wang","year":"2003","unstructured":"Wang W, Ma ESK, Chan AYY, Prior J, Erber WN, Chan LC, Chui DHK, Chong SS (2003) Single-tube multiplex-PCR screen for anti-3.7 and anti-4.2 \u03b1-globin gene triplications. Clin. Chem. 49(10):1679\u20131682","journal-title":"Clin. Chem."},{"key":"3536_CR37","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1046\/j.1365-2141.2000.01870.x","volume":"108","author":"YT Liu","year":"2000","unstructured":"Liu YT, Old JM, Miles K, Fisher CA, Weatherall DJ, Clegg JB (2000) Rapid detection of \u03b1-thalassaemia deletions and \u03b1-globin gene triplication by multiplex polymerase chain reactions. Br. J. Haematol. 108:295\u2013299","journal-title":"Br. J. Haematol."},{"key":"3536_CR38","doi-asserted-by":"crossref","first-page":"4838","DOI":"10.1182\/blood.V128.22.4838.4838","volume":"128","author":"PK Chowdhury","year":"2016","unstructured":"Chowdhury PK, Jena R, Chowdhury D (2016) Red cell indices as predictors of response to hydroxyurea therapy in HbE\/beta thalassaemia patients. Blood 128:4838","journal-title":"Blood"},{"key":"3536_CR39","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1196\/annals.1345.002","volume":"1054","author":"DJ Weatherall","year":"2005","unstructured":"Weatherall DJ (2005) The challenges of thalassaemia for the developing countries. Ann. N. Y. Acad. Sci. 1054:11\u201317","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"3536_CR40","first-page":"522","volume":"134","author":"NF Olivieri","year":"2011","unstructured":"Olivieri NF, Pakbaz Z, Vichinsky E (2011) HbE\/beta-thalassaemia: a common & clinibordbarcally diverse disorder. Indian J Med Res 134:522\u2013531","journal-title":"Indian J Med Res"},{"key":"3536_CR41","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1046\/j.1365-2141.1998.00719.x","volume":"101","author":"BR Saxon","year":"1998","unstructured":"Saxon BR, Rees D, Olivieri NF (1998) Regression of extramedullary haemopoiesis and augmentation of fetal haemoglobin concentration during hydroxyurea therapy in \u03b2 thalassaemia. Br. J. Haematol. 101:416\u2013419","journal-title":"Br. J. Haematol."},{"key":"3536_CR42","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.1182\/blood-2003-01-0117","volume":"102","author":"M Bradai","year":"2003","unstructured":"Bradai M, Abad MT, Pissard S, Lamraouni F, Skopinski L, de Montalembert M (2003) Hydroxyurea can eliminate transfusion requirements in children with severe \u03b2-thalassaemia. Blood 102:1529\u20131530","journal-title":"Blood"},{"key":"3536_CR43","doi-asserted-by":"publisher","first-page":"1486","DOI":"10.1016\/j.exphem.2005.09.006","volume":"33","author":"Y Watanapokasin","year":"2005","unstructured":"Watanapokasin Y, Chuncharunee S, Sanmund D, Kongnium W, Winichagoon P, Rodgers GP, Fucharoen S (2005) In vivo and in vitro studies of fetalhemoglobin induction by hydroxyurea in \u03b2-thalassemia \/haemoglobin E patients. Exp Hematol 33:1486\u20131492","journal-title":"Exp Hematol"},{"issue":"4","key":"3536_CR44","doi-asserted-by":"publisher","first-page":"e171","DOI":"10.1097\/MPH.0000000000000779","volume":"39","author":"M Karimi","year":"2017","unstructured":"Karimi M, Zarei T, Haghpanah S, Moghadam M, Ebrahimi A, Rezaei N, Heidari G, Vazin A, Khavari M, Miri HR (2017) Relationship between some single-nucleotide polymorphism and response to hydroxyurea therapy in Iranian patients with \u03b2-thalassemia intermedia. J. Pediatr. Hematol.\/Oncol. 39(4):e171\u2013e176","journal-title":"J. Pediatr. Hematol.\/Oncol."},{"issue":"1\u20132","key":"3536_CR45","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.cca.2009.06.019","volume":"407","author":"KY Italia","year":"2009","unstructured":"Italia KY, Jijina FJ, Merchant R, Panjwani S, Nadkarni AH, Sawant PM, Nair SB, Ghosh K, Colah RB (2009) Response to hydroxyurea in \u03b2 thalassemia major and intermedia: experience in western India. Clin. Chim. Acta 407(1\u20132):10\u201315","journal-title":"Clin. Chim. Acta"},{"key":"3536_CR46","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1007\/s00277-005-1026-4","volume":"84","author":"A Dixit","year":"2005","unstructured":"Dixit A, Chatterjee TC, Mishra P, Choudhry DR, Mahapatra M, Tyagi S, Kabra M, Saxena R, Choudhry VP (2005) Hydroxyurea in thalassemia intermedia\u2014a promising therapy. Ann. Hematol. 84:441\u2013446","journal-title":"Ann. Hematol."},{"key":"3536_CR47","volume-title":"The thalassaemia syndromes","author":"J David","year":"2001","unstructured":"David J, Weatherall JBC (2001) The thalassaemia syndromes, 4th edn. Oxford, UK, Blackwell Scientific","edition":"4"},{"issue":"6","key":"3536_CR48","doi-asserted-by":"publisher","first-page":"483","DOI":"10.5581\/1516-8484.20110128","volume":"33","author":"IS Chinelato","year":"2011","unstructured":"Chinelato IS, Carrocini GCS, Bonini-Domingos CR (2011) XmnI polymorphism frequency in heterozygote beta thalassemia subjects and its relation to fetal hemoglobin levels. Rev Bras Hematol Hemoter 33(6):483","journal-title":"Rev Bras Hematol Hemoter"},{"issue":"2","key":"3536_CR49","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.bcmd.2010.04.002","volume":"45","author":"TK Nguyen","year":"2010","unstructured":"Nguyen TK, Joly P, Bardel C, Moulsma M, Bonello-Palot N (2010) FrancinaA :the XmnI (G)gamma polymorphism influences hemoglobin F synthesis contrary to BCL11A and HBS1L-MYB SNPs in a cohort of 57 beta-thalassemia intermedia patients. Blood Cells Mol Dis 45(2):124\u2013127","journal-title":"Blood Cells Mol Dis"},{"issue":"4","key":"3536_CR50","first-page":"522","volume":"134","author":"NF Olivieri","year":"2011","unstructured":"Olivieri NF, Pakbaz Z, Vichinsky E (2011) Hb E\/beta-thalassaemia: a common & clinically diverse disorder. Indian J Med Res 134(4):522\u2013531","journal-title":"Indian J Med Res"},{"issue":"1","key":"3536_CR51","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.hemonc.2014.12.004","volume":"8","author":"N Ali","year":"2015","unstructured":"Ali N, Ayyub M, Khan SA, Ahmed S, Abbas K, Malik HS, Tashfeen S (2015) Frequency of G\u03b3-globin promoter \u2212158 (C>T) XmnI polymorphism in patients with homozygous\/compound heterozygous beta thalassaemia. HematolOncol Stem Cell Ther 8(1):10\u201315","journal-title":"HematolOncol Stem Cell Ther"},{"key":"3536_CR52","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1007\/s12185-011-0985-6","volume":"95","author":"M Karimi","year":"2012","unstructured":"Karimi M, Haghpanah S, Farhadi A, Yavarian M (2012) Genotype-phenotype relationship of patients with \u03b2-thalassemia taking hydroxyurea: a 13-year experience in Iran. Int J Hematol 95:51\u201356","journal-title":"Int J Hematol"},{"key":"3536_CR53","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1080\/10245330400020439","volume":"10","author":"I Panighari","year":"2005","unstructured":"Panighari I, Dixit A, Arora S, Kabra M, Mahapatra M, Choudhry VP, Saxena R (2005) Do alpha deletions influence hydroxyurea response in thalassaemia intermedia? Hematology 10:61\u201363","journal-title":"Hematology"},{"issue":"10","key":"3536_CR54","first-page":"1172","volume":"89","author":"M Yavarian","year":"2004","unstructured":"Yavarian M, Karimi M, Bakker E, Harteveld CL, Giordano PC (2004) Response to hydroxyurea treatment in Iranian transfusion dependent beta-thalassemia patients. Haematologica 89(10):1172\u20131178","journal-title":"Haematologica"},{"issue":"1\u20132","key":"3536_CR55","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.cca.2009.06.019","volume":"407","author":"KY Italia","year":"2009","unstructured":"Italia KY, Jijina FJ, Merchant R, Panjwani S, Nadkarni AH, Sawant PM (2009) Response to hydroxyurea in beta thalassemia major and intermedia: experience in western India. Clin. Chim. Acta 407(1\u20132):10\u201315","journal-title":"Clin. Chim. Acta"},{"issue":"2","key":"3536_CR56","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1136\/jcp.2009.070391","volume":"63","author":"KY Italia","year":"2010","unstructured":"Italia KY, Jijina FF, Merchant R, Panjwani S, Nadkarni AH, Sawant PM, Nair SB, Ghosh K, Colah RB (2010) Effect of hydroxyurea on the transfusion requirements in patients with severe HbE-beta-thalassaemia: a genotypic and phenotypic study. J Clin Pathol 63(2):147\u2013150","journal-title":"J Clin Pathol"},{"key":"3536_CR57","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1007\/s00277-002-0501-4","volume":"81","author":"H Cario","year":"2002","unstructured":"Cario H, Wegener M, Debatin KM, Kohne E (2002) Treatment with hydroxyurea in thalassemia intermedia with paravertebral pseudotumors of extramedullary hematopoiesis. Ann. Hematol. 81:478\u2013482","journal-title":"Ann. Hematol."},{"key":"3536_CR58","doi-asserted-by":"publisher","first-page":"1486","DOI":"10.1016\/j.exphem.2005.09.006","volume":"33","author":"Y Watanapokasin","year":"2005","unstructured":"Watanapokasin Y, Chuncharunee S, Sanmund D, Kongnium W, Winichagoon P, Rodgers GP, Fucharoen S (2005) In vivo and in vitro studies of fetal hemoglobin induction by hydroxyurea in \u03b2-thalassemia \/haemoglobin E patients. Exp Hematol 33:1486\u20131492","journal-title":"Exp Hematol"},{"key":"3536_CR59","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1034\/j.1600-0609.2003.00037.x","volume":"70","author":"EV Paula De","year":"2003","unstructured":"De Paula EV, Lima CSP, Arruda R, Alberto FL, Saad STO, Costa FF (2003) Long-term hydroxyurea therapy in beta-thalassaemia patients. Eur J Haematol 70:151\u2013155","journal-title":"Eur J Haematol"},{"issue":"11","key":"3536_CR60","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1002\/ajh.21266","volume":"83","author":"ST Sylvia","year":"2008","unstructured":"Sylvia ST, Elliott V, Sandra L, Nancy O, Nancy S, Frans KA (2008) Hydroxycarbamide-induced changes in E\/beta thalassaemia red blood cells. Am J Hematol 83(11):842\u2013845","journal-title":"Am J Hematol"},{"key":"3536_CR61","unstructured":"Treatment with hydroxyurea \u2013 \n                    thalassaemia.com\n                    \n                  . Experimental drug therapy to increase fetal haemoglobin. Treating Thalassaemia. Northern California comprehensive thalassaemia center"},{"key":"3536_CR62","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1056\/NEJM199703273361318","volume":"336","author":"VR Arruda","year":"1997","unstructured":"Arruda VR, Lima CSP, Saad STO, Costa FF (1997) Successful use of hydroxyurea in \u03b2-thalassemia major. N Engl J Med 336:964\u2013965","journal-title":"N Engl J Med"},{"issue":"3","key":"3536_CR63","first-page":"114","volume":"4","author":"A Ghasemi","year":"2014","unstructured":"Ghasemi A, Keikhaei B, Ghodsi R (2014) Side effects of hydroxyurea in patients with thalassaemia major and thalassaemia intermedia and sickle cell anaemia. Iran J PedHematol Oncol 4(3):114\u2013117","journal-title":"Iran J PedHematol Oncol"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00277-018-3536-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-018-3536-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-018-3536-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,8]],"date-time":"2019-11-08T19:11:50Z","timestamp":1573240310000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00277-018-3536-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11,9]]},"references-count":63,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,2]]}},"alternative-id":["3536"],"URL":"https:\/\/doi.org\/10.1007\/s00277-018-3536-x","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"value":"0939-5555","type":"print"},{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,11,9]]},"assertion":[{"value":"14 March 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 October 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 November 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"All procedures performed in this study involving human participants were in accordance with the ethical standards of the institutional and national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed written consent was obtained from all individual participants included in the study and parents of paediatric participants.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"The authors declare that they have no financial relationship with the organization that sponsored the research.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Financial relationship"}},{"value":"The authors declare that they have no conflict of interest.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}